Targeting the I7L Protease: A Rational Design for Anti-Monkeypox Drugs?

The latest monkeypox virus outbreak in 2022 showcased the potential threat of this viral zoonosis to public health. The lack of specific treatments against this infection and the success of viral protease inhibitors-based treatments against HIV, Hepatitis C, and SARS-CoV-2, brought the monkeypox vir...

Descripción completa

Detalles Bibliográficos
Autores principales: Dodaro, Andrea, Pavan, Matteo, Moro, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138331/
https://www.ncbi.nlm.nih.gov/pubmed/37108279
http://dx.doi.org/10.3390/ijms24087119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138331/
https://www.ncbi.nlm.nih.gov/pubmed/37108279
http://dx.doi.org/10.3390/ijms24087119

Ejemplares similares